Andere Sprachen Applied BioCode Corporation

Aktien

6598

KYG0488D1051

6598

Schlusskurs Taiwan S.E. Andere Börsenplätze 00:00:00 15.05.2024			% 5 Tage	% 1. Jan.
20 ^TWD	+1,01 %		-0,25 %	-20,95 %

15.04.	Applied BioCode kündigt die Markteinführung des STI + Resistance Panel Assay nur für Forschungszwecke an	CI
21.03.	Applied BioCode kündigt Wechsel des CEO an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15.04.
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15.04.
Applied BioCode Announces Retirement of CEO Chris Bernard	21.03.
Applied BioCode Announces CEO Changes	21.03.
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer	28.09.23
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer	28.09.23
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer	23.09.23
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28.08.23
Applied BioCode Corporation Announces the Change of Representative of Institutional Director	14.06.23
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use	12.06.23
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use	12.06.23
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12.05.23
Applied BioCode Announces Distribution Agreement with Medline Industries	08.05.23
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries	08.05.23
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22.03.23
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22.03.23
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer	13.03.23
Applied BioCode Announces 2022 Q4 and Full year Revenue	27.02.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Applied BioCode Corporation

Aktien

6598

KYG0488D1051

6598

Andere Sprachen

Filter